Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

With over half the cells in the human body being bacterial rather than human, and over 99% of the genes in the human body ...

and advanced causal inference methods made this research both intellectually challenging and deeply rewarding throughout my ...

The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...

Ensho has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day treatment for ...

we need to show that our predictions hold true in clinical trials that we hope to run in the future,” he explained. “People with inflammatory bowel disease are at increased risk of developing ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

A clinical study is underway that is testing whether an investigational medicine is safe and whether it may work to help ...

Clinical trials help researchers studying chronic conditions answer important questions about the diseases and their treatment options. However, uncertainty about what to expect and a lack of ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...

Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...